YU42298A - Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola - Google Patents

Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola

Info

Publication number
YU42298A
YU42298A YU42298A YU42298A YU42298A YU 42298 A YU42298 A YU 42298A YU 42298 A YU42298 A YU 42298A YU 42298 A YU42298 A YU 42298A YU 42298 A YU42298 A YU 42298A
Authority
YU
Yugoslavia
Prior art keywords
olanzapine
praparation
acute pain
treating acute
medicine useful
Prior art date
Application number
YU42298A
Other languages
English (en)
Inventor
David Reed Helton
Mary Jeanne Kallman
Harlan Edgar Shannon
Daniel Edvard Womer
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU42298A publication Critical patent/YU42298A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

Opisana je upotreba olanzapina za pripremu leka za tretiranje akutnog bola nastalog iz različitih uzroka.
YU42298A 1996-03-25 1998-09-25 Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola YU42298A (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1415396P 1996-03-25 1996-03-25
US1413196P 1996-03-25 1996-03-25
US1413396P 1996-03-25 1996-03-25

Publications (1)

Publication Number Publication Date
YU42298A true YU42298A (sh) 1999-09-27

Family

ID=27360028

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42298A YU42298A (sh) 1996-03-25 1998-09-25 Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola

Country Status (14)

Country Link
US (1) US6258807B1 (sh)
EP (1) EP0910381A4 (sh)
JP (1) JP2001517202A (sh)
CN (1) CN1219878A (sh)
AU (1) AU721338B2 (sh)
BR (1) BR9708246A (sh)
CA (1) CA2248873A1 (sh)
CZ (1) CZ298198A3 (sh)
EA (1) EA199800866A1 (sh)
IL (1) IL126064A0 (sh)
NO (1) NO984446L (sh)
PL (1) PL329217A1 (sh)
WO (1) WO1997035583A1 (sh)
YU (1) YU42298A (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250187A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Composition comprising olanzapine and a drug useful in the treatment of pain for use in the treatment of pain
JP2000507546A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 麻酔方法
CN1726037B (zh) * 2002-11-26 2010-05-05 艾利斯达医药品公司 抗精神病药用于制备通过吸入传送治疗头痛的药物中的应用
CA2507159A1 (en) 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
JP4964593B2 (ja) * 2003-09-25 2012-07-04 セノメド バイオサイエンシーズ，エルエルシー 神経学的病状の治療用のテトラヒドロインドロン誘導体
US20050107439A1 (en) * 2003-11-10 2005-05-19 Helton David R. Composition and method for treating emesis
US7402777B2 (en) 2004-05-20 2008-07-22 Alexza Pharmaceuticals, Inc. Stable initiator compositions and igniters
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
WO2009062134A1 (en) * 2007-11-09 2009-05-14 Cenomed Biosciences, Llc Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
US20090264443A1 (en) * 2008-04-18 2009-10-22 David Helton Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
US20150216206A1 (en) 2012-07-31 2015-08-06 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Method for increasing meat and milk production
EA201590048A1 (ru) 2012-07-31 2015-09-30 Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. Применение оланзапина у животных
CN106243096B (zh) * 2016-07-29 2019-11-29 上海璃道医药科技有限公司 三环类药物的新用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994924A (en) * 1975-11-04 1976-11-30 American Cyanamid Company 4,5,6,7-Tetra hydro-7-oxobenzo(B)thien-4-yl isocyanate and isothiocyanate
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
ES2153373T3 (es) * 1992-05-29 2001-03-01 Lilly Co Eli Derivados de tienobenzodiazepina para el tratamiento de trastornos del sistema nervioso central.
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
US5605911A (en) * 1995-01-31 1997-02-25 Washington University Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
CN1106196C (zh) * 1996-03-25 2003-04-23 伊莱利利公司 奥氮平在制备用于治疗偏头痛的药物中的应用
CA2250187A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Composition comprising olanzapine and a drug useful in the treatment of pain for use in the treatment of pain
JP2000507546A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 麻酔方法

Also Published As

Publication number Publication date
CA2248873A1 (en) 1997-10-02
IL126064A0 (en) 1999-05-09
US6258807B1 (en) 2001-07-10
WO1997035583A1 (en) 1997-10-02
EP0910381A1 (en) 1999-04-28
AU721338B2 (en) 2000-06-29
NO984446D0 (no) 1998-09-24
BR9708246A (pt) 1999-07-27
NO984446L (no) 1998-11-25
JP2001517202A (ja) 2001-10-02
EP0910381A4 (en) 2002-10-09
PL329217A1 (en) 1999-03-15
CN1219878A (zh) 1999-06-16
AU2340897A (en) 1997-10-17
EA199800866A1 (ru) 1999-06-24
CZ298198A3 (cs) 1999-06-16

Similar Documents

Publication Publication Date Title
NO20013727D0 (no) Anvendelse av Botulinumtoksin B for fremstilling av et medikament
CY1109972T1 (el) Χρηση τοξινης αλλαντιασης για τη θεραπευτικη αγωγη του πονου της νεραλγιας
ES2163504T3 (es) Formas de dosificacion de liberacion controlada de azitromicina.
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
YU40098A (sh) Upotreba olanzapina za dobijanje leka
ATE337783T1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
NO984198L (no) FremgangsmÕte for behandling av aggresjon
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
UA40215A (uk) Спосіб лікування дітей, хворих на пневмонію
ES2139382T3 (es) Sistema terapeutico percutaneo para compuestos de silatran.
UA10259A (uk) Протинабряковий лікарський препарат "нейрополіосм"
ES1004875Y (es) Nuevo vendaje terapeutico.
BR7500523U (pt) Meias descartáveis para tratamento medicinal
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen